毒性分類
出自台灣有毒中草藥毒性資料庫
(修訂版本間的差異)
第12行: | 第12行: | ||
<font size=3>'''Class A'''</font> | <font size=3>'''Class A'''</font> | ||
||<font size=3> Randomized controlled trials have been demonstrated risks or effects to the human bodies.</font> | ||<font size=3> Randomized controlled trials have been demonstrated risks or effects to the human bodies.</font> | ||
+ | ||<font size=3>5</font> | ||
|- | |- | ||
|| | || | ||
<font size=3>'''Class B1'''</font> | <font size=3>'''Class B1'''</font> | ||
||<font size=3>Drugs which have been investigated via in vivo tests showed potential harmful to human bodies and we need more clinical trials to confirm the toxicity to human.</font> | ||<font size=3>Drugs which have been investigated via in vivo tests showed potential harmful to human bodies and we need more clinical trials to confirm the toxicity to human.</font> | ||
+ | ||<font size=3>4</font> | ||
|- | |- | ||
|| | || | ||
<font size=3>'''Class B2'''</font> | <font size=3>'''Class B2'''</font> | ||
||<font size=3> Drugs which have been investigated via in vitro tests showed potential harmful to human bodies and further studies should be carried out to confirm it.</font> | ||<font size=3> Drugs which have been investigated via in vitro tests showed potential harmful to human bodies and further studies should be carried out to confirm it.</font> | ||
+ | ||<font size=3>3</font> | ||
|- | |- | ||
|| | || | ||
<font size=3>'''Class C'''</font> | <font size=3>'''Class C'''</font> | ||
||<font size=3>expert opinion, case reports or case series</font> | ||<font size=3>expert opinion, case reports or case series</font> | ||
+ | ||<font size=3>2</font> | ||
|- | |- | ||
|| | || | ||
<font size=3>'''Class D'''</font> | <font size=3>'''Class D'''</font> | ||
||<font size=3>no evidence</font> | ||<font size=3>no evidence</font> | ||
+ | ||<font size=3>1</font> | ||
|} | |} |
在2011年11月3日 (四) 03:02所做的修訂版本
本毒性分級主要參考MICROMEDEX中,RECOMMENDATION, EVIDENCE AND EFFICACY RATINGS的定義來設定資料庫的毒性等級。
級數 |
說明 |
分數 |
Class A | Randomized controlled trials have been demonstrated risks or effects to the human bodies. | 5 |
Class B1 | Drugs which have been investigated via in vivo tests showed potential harmful to human bodies and we need more clinical trials to confirm the toxicity to human. | 4 |
Class B2 | Drugs which have been investigated via in vitro tests showed potential harmful to human bodies and further studies should be carried out to confirm it. | 3 |
Class C | expert opinion, case reports or case series | 2 |
Class D | no evidence | 1 |